New Zealand’s High Court has struck down restrictions on puberty blockers for transgender young people, ruling that the government acted unlawfully and discriminated against those affected.
A major victory for transgender rights has emerged from New Zealand, where the High Court has overturned government regulations restricting new prescriptions of puberty blockers to young people experiencing gender dysphoria.
The decision, delivered on 21 October 2026, found that the government had failed to properly consult those affected and that the restrictions amounted to unjustified discrimination.
But what does the ruling actually change?
Why Did New Zealand Restrict Puberty Blockers?
In November 2025, the New Zealand government introduced regulations preventing doctors from issuing new prescriptions of puberty blockers to under-18s for gender dysphoria or gender incongruence.
Puberty blockers are medications that temporarily suppress certain physical changes associated with puberty.
The government argued that restrictions were necessary because of uncertainty surrounding the long-term benefits and risks of the treatment.
However, the Professional Association for Transgender Health Aotearoa (PATHA) challenged the decision in court.
What Did the High Court Decide?
Justice Dale La Hood ruled that the government had not adequately consulted those affected by the proposed restrictions.
Importantly, transgender and gender-diverse young people had not been directly consulted about a policy that would significantly affect their healthcare.
The court also found that the indefinite prohibition on new prescriptions breached New Zealand’s legal protections against discrimination.
The ruling did not establish that puberty blockers carry no medical risks. Instead, it found that the government’s approach was unlawful and that a blanket restriction was disproportionate.
What Happens to Transgender Young People Now?
The regulations have been set aside, removing the specific prohibition on new prescriptions.
However, this does not mean puberty blockers will automatically be prescribed to every transgender young person requesting them.
Access remains subject to clinical assessments, professional guidance and healthcare availability.
The government is considering its next steps, while New Zealand First has called for the judgment to be appealed.
Meanwhile, healthcare organisation Sexual Wellbeing Aotearoa welcomed the ruling, arguing that healthcare decisions should involve medical professionals, patients and their families.
A Significant Ruling Beyond New Zealand
The judgment comes as several countries continue to debate access to gender-affirming healthcare for young people.
In the UK, restrictions on puberty blockers have become one of the most contested issues in transgender healthcare, while the United States continues to experience significant differences between state and federal policies.
But it establishes something important: governments must follow the law, consult those affected and justify restrictions that discriminate against vulnerable groups.
Young transgender people deserve to be heard when decisions are made about their healthcare. The High Court has made clear that excluding them from that conversation has legal consequences.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Skip to content
